Shepherd Center is a private, not-for profit hospital in Atlanta, Georgia. Founded in 1975, the 152-bed hospital focuses on the medical treatment, research and rehabilitation for people with spinal cord injury and disease, acquired brain injury, multiple sclerosis, chronic pain and other neuromuscular problems.

During the past decade, Shepherd Center conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 13 clinical trials were completed, i.e. on average, 46.4% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 8 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shepherd Center" #1 sponsor was "Shepherd Center, Atlanta GA" with 15 trials, followed by "Acorda Therapeutics" with 6 trials sponsored, "Boston Scientific Corporation" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Jazz Pharmaceuticals" with 2 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shepherd Center" #1 collaborator was "Shepherd Center, Atlanta GA" with 6 trials as a collaborator, "Shirley Ryan AbilityLab" with 3 trials as a collaborator, "Emory University" with 2 trials as a collaborator, "National Institute on Disability, Independent Living, and Rehabilitation Research" with 2 trials as a collaborator and "Northwestern University" with 2 trials as a collaborator. Other collaborators include 32 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "Shepherd Center" are "Multiple Sclerosis" (13 trials), "Spinal Cord Injury" (12 trials), "Spinal Cord Injuries" (9 trials), "Tetraplegia" (5 trials) and "Cervical Spinal Cord Injury" (2 trials). Many other conditions were trialed in "Shepherd Center" in a lesser frequency.

Most popular intervention types in "Shepherd Center" are "Drug" (20 trials), "Device" (12 trials), "Other" (11 trials), "Behavioral" (7 trials) and "Biological" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Fampridine-SR" (4 trials), "Ocrelizumab" (3 trials), "Interferon beta-1a" (2 trials) and "Transcutaneous spinal stimulation" (2 trials). Other intervention names were less common.

The vast majority of trials in "Shepherd Center" are 57 trials for "All" genders.

Currently, there are NaN active trials in "Shepherd Center". undefined are not yet recruiting, 6 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 40 completed trials in Shepherd Center, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Shepherd Center, 6 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 21 trials that are defined as “Not Applicable".